Invivoscribe Competitors and Similar CompaniesClear all
MaveriX Oncology's competitors and similar companies include eTheRNA.
 MaveriX Oncology MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies. |  eTheRNA eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform. | |
Founding Date | Founding Date 2014 | Founding Date 2013 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Palo Alto, US HQ | Locations Antwerp, BE HQ Ghent, BE Hong Kong, HK Boston, US |
Employees | Employees 3 | Employees 1104% decrease |
Funding | ||
Latest funding round | Latest funding round $ 6.5m (over 6 years ago) | Latest funding round $ 38.3m (almost 6 years ago) |
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 66.3m |
For sources of this data, please see the company profile
View Company Profiles
eTheRNA
HQ
Antwerp, BE
Employees
110↓ 4% decrease
eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform.
View company